Monitoring dapsone self-administration in a multidrug therapy programme.
D000293:Adolescent; D000328:Adult; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000008:administration & dosage* / Q000627:therapeutic use / Q000652:urine; D004359:Drug Therapy, Combination; D005002:Ethiopia; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012293:Rifampin / Q000627:therapeutic use; D012646:Self Administration
D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin